New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:01 EDTFLDMFluidigm price target raised to $47 from $28 at Cantor
Cantor increased its price target on Fluidigm after the company acquired privately held DVS Sciences. The firm thinks the deal further strengthens and diversifies Fluidigm's already highly capabilities in single-cell genomics, and leaves the company better positioned to accelerate market expansion for single-cell analysis. The firm keeps a Buy rating on the stock.
News For FLDM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTFLDMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 20, 2015
07:53 EDTFLDMFluidigm upgraded to Outperform at Cowen
Subscribe for More Information
06:36 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
January 13, 2015
16:02 EDTFLDMFluidigm sees FY15 revenue $142M-$149M, consensus $149.02M
Subscribe for More Information
16:02 EDTFLDMFluidigm sees FY14 revenue approximately $116.4M, consensus $116.27M
Organic revenue for the full year of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF 2 system and proteomics analytical consumables) is expected to be approximately $95.9M.
16:01 EDTFLDMFluidigm sees Q4 revenue approximately $33.4M, consensus $33.33M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use